| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001917 |
| Receipt No. | R000002335 |
| Scientific Title | Demonstration of the Usefulness for the Evaluation by Real-time 3D Echocardiography, Speckle Tracking and tissue Doppler Echocardiography in Patients with a First ST-Elevation Acute Myocardial Infarction |
| Date of disclosure of the study information | 2009/04/29 |
| Last modified on | 2020/11/06 (Ver. 14) |
| Basic information | ||
| Public title | Demonstration of the Usefulness for the Evaluation by Real-time 3D Echocardiography, Speckle Tracking and tissue Doppler Echocardiography in Patients with a First ST-Elevation Acute Myocardial Infarction | |
| Acronym | DUAL-ECHO | |
| Scientific Title | Demonstration of the Usefulness for the Evaluation by Real-time 3D Echocardiography, Speckle Tracking and tissue Doppler Echocardiography in Patients with a First ST-Elevation Acute Myocardial Infarction | |
| Scientific Title:Acronym | DUAL-ECHO | |
| Region |
|
|
| Condition | ||
| Condition | Patients with first ST-elevation acute myocardial infarction(STEMI) who successfully underwent emergent PCI within 24 hours of onset. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To explore the usefulness of real-time 3D echocardiography on the evaluation for a first STEMI. If possible, we were planning to perform tissue Doppler, speckle tracking echo and three dimensional speckle tracking echo. We had a lot of data who had 2 weeks after onset of AMI, therefore we will explore to resolve the difference of usefulness of tissue Doppler echo in terms of the results of these two reserch(24 hours after admission vs. 2weeks sfter onset). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | EF. EDV(I). ESV(I). BNP. Remodeling. |
| Key secondary outcomes | MACCE(Major adverse cardiac and cerebrovascular events). |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects who successfully underwent emergent PCI for their first STEMI within 12 hours of onset. Age is greater than 20 years-old. | |||
| Key exclusion criteria | 1)Younger than 20 years old.
2)History of prior myocardial infarction. 3)Unstable angina pectoris after AMI. 4)According to the attending physician's judgment, because of patients' unconsciousness or dementia. 5)Impossible to obtain informed written consent. 6)Subjects with contraindication for CAG, such as patients with hypersensitivity to iodine. 7)History of prior PCI or CABG. 8)Subjects who could not undergo 99mTc MIBI. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Medical Center | ||||||
| Division name | Division of Cardiology | ||||||
| Zip code | 232-0024 | ||||||
| Address | 4-57 Urafune-chou, Minami-ku, Yokohama. | ||||||
| TEL | 045-261-5656 | ||||||
| niwahash@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Medical Center | ||||||
| Division name | Division of Cardiology | ||||||
| Zip code | 232-0024 | ||||||
| Address | 4-57 Urafune-chou, Minami-ku, Yokohama. | ||||||
| TEL | 045-261-5656 | ||||||
| Homepage URL | |||||||
| niwahash@urahp.yokohama-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | YCU novel and clinical trail center |
| Address | Fukuura Kanazawa-ku Yokohama |
| Tel | 045-787-2800 |
| ynext@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 横浜市立大学付属市民総合医療センター
Yokohama City University Medical Center |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | The purpose of this study is to explore the usefulness of real-time 3D echocardiography (RT3DE) on the evaluation for a first ST-elavation acute myocardial infarction(STEMI). Subjects are the patients with first STEMI who successfully underwent emergent PCI within 24 hours of onset. They will undergo 99mTc MIBI at 2 weeks. Furthermore, we will examine RT3DE after 10months repeatedly to measure their left ventricular size and function. We will explore if the measurements by RT3DE could predict left ventricular remodeling and prognosis of the patients after a first STEMI. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000002335 |